SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Canada's Helus Pharma Q2 net loss widens on higher operating expenses

Canada's Helus Pharma Q2 net loss widens on higher operating expenses Overview Canada clinical-stage

GHRS

Related stories